BioNexus Gene Lab Corp Common stock — Quarterly Financial Statements (NASDAQ:BGLC) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Market Capitalization 5.1179 M
Employee 1
Founded 2017
CEO N/A
Website www.bionexusgenelab.com
Headquarter Wyoming, United States
FIGI BBG00N70PLY0
Industry Specialty Chemicals

Total revenue

Net income

Total debt

Free cash flow

Cash & equivalents

5.12 M Market capitalization

Price to earnings ratio

—

Price to sales ratio

—

News

BioNexus Gene Lab appoints commercial officer at Fidelion

BioNexus Gene Lab completes strategic deal with Fidelion Diagnostics

BioNexus Gene Lab stock falls after securing $500M equity facility

BioNexus Gene Lab secures $500 million equity purchase agreement

BioNexus Gene Lab stock climbs after securing $500 million equity facility

BioNexus Gene Lab forms partnership to commercialize liquid biopsy platform

BioNexus Gene Lab stock soars after strategic MRD testing agreements

BioNexus Gene Lab files $100 million shelf registration, launches ATM program

BioNexus Gene Lab enters strategic partnership talks with BirchBioMed

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.38%

US Stocks Edge Higher; Kraft Heinz Earnings Top Views - BioNexus Gene Lab (NASDAQ:BGLC), Kraft Heinz (NASDAQ:KHC)

Why Interactive Brokers Group Shares Are Trading Higher By 5%; Here Are 20 Stocks Moving Premarket - BioNexus Gene Lab (NASDAQ:BGLC), 180 Life Sciences (NASDAQ:ATNF)